At 7.2% CAGR, the Pre-Filled Saline Syringes market is estimated to accumulate US$ 744.4 Mn in 2027, says The Insight Partners

According to The Insight Partners market research study titled ‘Pre-filled Saline Syringes Market - Global Analysis and Forecasts by Type, End User, and Geography.’ The Global Pre-Filled Saline Syringes Market is expected to reach US$ 744.4 Mn in 2027 from US$ 402.5 Mn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027. The report highlights the trends prevalent in the global pre-filled saline syringes market and the factors driving the market along with those that act as deterrents to its growth.

Global pre-filled saline syringes market, based on the type was segmented into 3ml Syringes, 5ml Syringes, 10ml Syringes, and Others.  In 2018, the 3 ml Syringes segment held the largest share of the market, by type. This segment is also expected to dominate the market in 2027 owing to high demand for hospital disposables, ease of use, easy availability, and the growing number of multispecialty hospitals. Moreover, the 3 ml syringe segment is anticipated to witness the significant growth rate of 7.8% during the forecast period owing to the factors such as the rising prevalence of chronic diseases and hospital acquired diseases that trigger increased utilization of pre-filled saline syringes which helps to avoid the cross medication.

Key factors driving the market are increasing medication errors, risk of cross-contamination in multi-dose vials, increase in, and self-injectable medicines to avoid visits to hospitals. However, factors such as frequent product recall and stringent regulatory requirements can restrict market growth.

Some of the prominent players operating in the market are, BD, Cardinal Health, MedXL Inc., Guerbet Group, Sterisets Medical Products, DBM, B. Braun Medical Inc., Wolf Medical Inc., Aquabiliti and Baxter Healthcare Corporation. The market players are focused on bringing new and innovative products to sustain their position in the market. For instance, in September 2018, MedXL expanded the business by registering its products of pre-filled saline syringes in Singapore.